Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management

European Journal of Radiology Open - Tập 9 - Trang 100419 - 2022
Man Pyo Chung1, Jiwon Hwang2, Joungho Han3, Ho Yun Lee4, Hiroto Hatabu5, Yunjoo Im1, Takuya Hino5,6, Kyung Soo Lee7, Teri J. Franks8, Hongseok Yoo1
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (SKKU-SOM), Seoul, South Korea
2Division of Rheumatology, Department of internal medicine, Samsung ChangWon Hospital, Sungkyunkwan University School of Medicine (SKKU-SOM), ChangWon, Gyeongsangnam-do, South Korea
3Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine (SKKU-SOM), Seoul, South Korea
4Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine (SKKU-SOM), Seoul, South Korea
5Center for Pulmonary Functional Imaging, Department of Radiology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
6Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka, 8128582, Japan
7Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine (SKKU-SOM), ChangWon, Gyeongsangnam-do, South Korea
8Pulmonary & Mediastinal Pathology, Department of Defense, The Joint Pathology Center, Silver Spring, Maryland, USA

Tóm tắt

Connective tissue diseases (CTDs) demonstrating features of interstitial lung disease (ILD) include systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), dermatomyositis (DM) and polymyositis (PM), ankylosing spondylitis (AS), Sjogren syndrome (SS), and mixed connective tissue disease (MCTD). On histopathology of lung biopsy in CTD-related ILDs (CTD-ILDs), multi-compartment involvement is an important clue, and when present, should bring CTD to the top of the list of etiologic differential diagnoses. Diverse histologic patterns including nonspecific interstitial pneumonia (NSIP), usual interstitial pneumonia (UIP), organizing pneumonia, apical fibrosis, diffuse alveolar damage, and lymphoid interstitial pneumonia can be seen on histology in patients with CTD-ILDs. Although proportions of ILDs vary, the NSIP pattern accounts for a large proportion, especially in SSc, DM and/or PM and MCTD, followed by the UIP pattern. In RA patients, interstitial lung abnormality (ILA) is reported to occur in approximately 20–60% of individuals of which 35–45% will have progression of the CT abnormality. Subpleural distribution and greater baseline ILA involvement are risk factors associated with disease progression. Asymptomatic CTD-ILDs or ILA patients with normal lung function and without evidence of disease progression can be followed without treatment. Immunosuppressive or antifibrotic agents for symptomatic and/or fibrosing CTD-ILDs can be used in patients who require treatment.

Từ khóa

#Connective tissue disease #Interstitial lung abnormality #Interstitial lung disease

Tài liệu tham khảo

null [2] D.J. Lederer F.J. Martinez Idiopathic pulmonary fibrosis New Engl. J. Med. 378 2018 1811 1823 10.1056/NEJMra1705751 D.J. Lederer, F.J. Martinez, Idiopathic Pulmonary Fibrosis, N Engl J Med 378 (2018) 1811–1823. https://doi.org/10.1056/NEJMra1705751. [3] C.J. Ryerson H.R. Collard Update on the diagnosis and classification of ILD Curr. Opin. Pulm. Med. 19 2013 453 459 10.1097/MCP.0b013e328363f48d C.J. Ryerson, H.R. Collard, Update on the diagnosis and classification of ILD, Curr Opin Pulm Med 19 (2013) 453–459. https://doi.org/10.1097/MCP.0b013e328363f48d. [4] C.T. Lee J.M. Oldham Interstitial pneumonia with autoimmune features: overview of proposed criteria and recent cohort characterization Clin. Pulm. Med. 24 2017 191 196 10.1097/CPM.0000000000000227 C.T. Lee, J.M. Oldham, Interstitial Pneumonia with Autoimmune Features: Overview of proposed criteria and recent cohort characterization, Clin Pulm Med 24 (2017) 191–196. https://doi.org/10.1097/CPM.0000000000000227. [5] A. Fischer R. du Bois Interstitial lung disease in connective tissue disorders Lancet 380 2012 689 698 10.1016/S0140-6736(12)61079-4 A. Fischer, R. du Bois, Interstitial lung disease in connective tissue disorders, Lancet 380 (2012) 689–698. https://doi.org/10.1016/S0140–6736(12)61079–4. [6] I. Mira-Avendano A. Abril C.D. Burger P.F. Dellaripa A. Fischer M.B. Gotway A.S. Lee J.S. Lee E.L. Matteson E.S. Yi J.H. Ryu Interstitial lung disease and other pulmonary manifestations in connective tissue diseases Mayo Clin. Proc. 94 2019 309 325 10.1016/j.mayocp.2018.09.002 I. Mira-Avendano, A. Abril, C.D. Burger, P.F. Dellaripa, A. Fischer, M.B. Gotway, A.S. Lee, J.S. Lee, E.L. Matteson, E.S. Yi, J.H. Ryu, Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases, Mayo Clin Proc 94 (2019) 309–325. https://doi.org/10.1016/j.mayocp.2018.09.002. [7] C. Vacchi M. Sebastiani G. Cassone S. Cerri G. Della Casa C. Salvarani A. Manfredi Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. A narrative review J. Clin. Med. 9 2020 10.3390/jcm9020407 C. Vacchi, M. Sebastiani, G. Cassone, S. Cerri, G. Della Casa, C. Salvarani, A. Manfredi, Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review, J Clin Med 9 (2020). https://doi.org/10.3390/jcm9020407. [8] N. Jeganathan M. Sathananthan Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment Lung 198 2020 735 759 10.1007/s00408-020-00383-w N. Jeganathan, M. Sathananthan, Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment, Lung 198 (2020) 735–759. https://doi.org/10.1007/s00408–020-00383-w. [9] M. Wijsenbeek V. Cottin Spectrum of fibrotic lung diseases New Engl. J. Med. 383 2020 958 968 10.1056/NEJMra2005230 M. Wijsenbeek, V. Cottin, Spectrum of Fibrotic Lung Diseases, N Engl J Med 383 (2020) 958–968. https://doi.org/10.1056/NEJMra2005230. [10] E.A. Kim K.S. Lee T. Johkoh T.S. Kim G.Y. Suh O.J. Kwon J. Han Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings Radiographics 2002 S151 S165 10.1148/radiographics.22.suppl_1.g02oc04s151 E.A. Kim, K.S. Lee, T. Johkoh, T.S. Kim, G.Y. Suh, O.J. Kwon, J. Han, Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings, Radiographics 22 Spec No (2002) S151-S165. https://doi.org/10.1148/radiographics.22.suppl_1.g02oc04s151. [11] J.H. Park D.S. Kim I.N. Park S.J. Jang M. Kitaichi A.G. Nicholson T.V. Colby Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes Am. J. Respir. Crit. Care Med. 175 2007 705 711 10.1164/rccm.200607-912OC J.H. Park, D.S. Kim, I.N. Park, S.J. Jang, M. Kitaichi, A.G. Nicholson, T.V. Colby, Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes, Am J Respir Crit Care Med 175 (2007) 705–711. https://doi.org/10.1164/rccm.200607–912OC. [12] V. Navaratnam N. Ali C.J. Smith T. McKeever A. Fogarty R.B. Hubbard Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? Respir. Med 105 2011 1925 1930 10.1016/j.rmed.2011.08.015 V. Navaratnam, N. Ali, C.J. Smith, T. McKeever, A. Fogarty, R.B. Hubbard, Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?, Respir Med 105 (2011) 1925–1930. https://doi.org/10.1016/j.rmed.2011.08.015. [13] G. Raghu M. Remy-Jardin J.L. Myers L. Richeldi C.J. Ryerson D.J. Lederer J. Behr V. Cottin S.K. Danoff F. Morell K.R. Flaherty A. Wells F.J. Martinez A. Azuma T.J. Bice D. Bouros K.K. Brown H.R. Collard A. Duggal L. Galvin Y. Inoue R.G. Jenkins T. Johkoh E.A. Kazerooni M. Kitaichi S.L. Knight G. Mansour A.G. Nicholson S.N.J. Pipavath I. Buendia-Roldan M. Selman W.D. Travis S. Walsh K.C. Wilson E.R.S.J.R.S. American Thoracic Society S. Latin American Thoracic Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline Am. J. Respir. Crit. Care Med. 198 2018 e44 e68 10.1164/rccm.201807-1255ST G. Raghu, M. Remy-Jardin, J.L. Myers, L. Richeldi, C.J. Ryerson, D.J. Lederer, J. Behr, V. Cottin, S.K. Danoff, F. Morell, K.R. Flaherty, A. Wells, F.J. Martinez, A. Azuma, T.J. Bice, D. Bouros, K.K. Brown, H.R. Collard, A. Duggal, L. Galvin, Y. Inoue, R.G. Jenkins, T. Johkoh, E.A. Kazerooni, M. Kitaichi, S.L. Knight, G. Mansour, A.G. Nicholson, S.N.J. Pipavath, I. Buendia-Roldan, M. Selman, W.D. Travis, S. Walsh, K.C. Wilson, E.R.S.J.R.S. American Thoracic Society, S. Latin American Thoracic, Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline, Am J Respir Crit Care Med 198 (2018) e44-e68. https://doi.org/10.1164/rccm.201807–1255ST. [14] B. Bradley H.M. Branley J.J. Egan M.S. Greaves D.M. Hansell N.K. Harrison N. Hirani R. Hubbard F. Lake A.B. Millar W.A. Wallace A.U. Wells M.K. Whyte M.L. Wilsher B.T.S.So.C.C. British Thoracic Society Interstitial Lung Disease Guideline Group A. Thoracic Society of S. New Zealand Thoracic S. Irish Thoracic Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society Thorax 63 Suppl 5 2008 v1 v58 10.1136/thx.2008.101691 B. Bradley, H.M. Branley, J.J. Egan, M.S. Greaves, D.M. Hansell, N.K. Harrison, N. Hirani, R. Hubbard, F. Lake, A.B. Millar, W.A. Wallace, A.U. Wells, M.K. Whyte, M.L. Wilsher, B.T.S.So.C.C. British Thoracic Society Interstitial Lung Disease Guideline Group, A. Thoracic Society of, S. New Zealand Thoracic, S. Irish Thoracic, Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society, Thorax 63 Suppl 5 (2008) v1-v58. https://doi.org/10.1136/thx.2008.101691. [15] H. Hatabu G.M. Hunninghake D.A. Lynch Interstitial lung abnormality: recognition and perspectives Radiology 291 2019 1 3 10.1148/radiol.2018181684 H. Hatabu, G.M. Hunninghake, D.A. Lynch, Interstitial Lung Abnormality: Recognition and Perspectives, Radiology 291 (2019) 1–3. https://doi.org/10.1148/radiol.2018181684. [16] A. Hata M.L. Schiebler D.A. Lynch H. Hatabu Interstitial lung abnormalities: state of the art Radiology 301 2021 19 34 10.1148/radiol.2021204367 A. Hata, M.L. Schiebler, D.A. Lynch, H. Hatabu, Interstitial Lung Abnormalities: State of the Art, Radiology 301 (2021) 19–34. https://doi.org/10.1148/radiol.2021204367. [17] H. Hatabu G.M. Hunninghake L. Richeldi K.K. Brown A.U. Wells M. Remy-Jardin J. Verschakelen A.G. Nicholson M.B. Beasley D.C. Christiani R. San Jose Estepar J.B. Seo T. Johkoh N. Sverzellati C.J. Ryerson R. Graham Barr J.M. Goo J.H.M. Austin C.A. Powell K.S. Lee Y. Inoue D.A. Lynch Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner Society Lancet Respir. Med. 8 2020 726 737 10.1016/S2213-2600(20)30168-5 H. Hatabu, G.M. Hunninghake, L. Richeldi, K.K. Brown, A.U. Wells, M. Remy-Jardin, J. Verschakelen, A.G. Nicholson, M.B. Beasley, D.C. Christiani, R. San Jose Estepar, J.B. Seo, T. Johkoh, N. Sverzellati, C.J. Ryerson, R. Graham Barr, J.M. Goo, J.H.M. Austin, C.A. Powell, K.S. Lee, Y. Inoue, D.A. Lynch, Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society, Lancet Respir Med 8 (2020) 726–737. https://doi.org/10.1016/S2213–2600(20)30168–5. [18] J.R. Mayo CT evaluation of diffuse infiltrative lung disease: dose considerations and optimal technique J. Thorac. Imaging 24 2009 252 259 10.1097/RTI.0b013e3181c227b2 J.R. Mayo, CT evaluation of diffuse infiltrative lung disease: dose considerations and optimal technique, J Thorac Imaging 24 (2009) 252–259. https://doi.org/10.1097/RTI.0b013e3181c227b2. [19] J.A. Verschakelen The role of high-resolution computed tomography in the work-up of interstitial lung disease Curr. Opin. Pulm. Med. 16 2010 503 510 10.1097/MCP.0b013e32833cc997 J.A. Verschakelen, The role of high-resolution computed tomography in the work-up of interstitial lung disease, Curr Opin Pulm Med 16 (2010) 503–510. https://doi.org/10.1097/MCP.0b013e32833cc997. [20] B.J. Bartholmai S. Raghunath R.A. Karwoski T. Moua S. Rajagopalan F. Maldonado P.A. Decker R.A. Robb Quantitative computed tomography imaging of interstitial lung diseases J. Thorac. Imaging 28 2013 298 307 10.1097/RTI.0b013e3182a21969 B.J. Bartholmai, S. Raghunath, R.A. Karwoski, T. Moua, S. Rajagopalan, F. Maldonado, P.A. Decker, R.A. Robb, Quantitative computed tomography imaging of interstitial lung diseases, J Thorac Imaging 28 (2013) 298–307. https://doi.org/10.1097/RTI.0b013e3182a21969. [21] W.D. Travis G. Hunninghake T.E. King Jr. D.A. Lynch T.V. Colby J.R. Galvin K.K. Brown M.P. Chung J.F. Cordier R.M. du Bois K.R. Flaherty T.J. Franks D.M. Hansell T.E. Hartman E.A. Kazerooni D.S. Kim M. Kitaichi T. Koyama F.J. Martinez S. Nagai D.E. Midthun N.L. Muller A.G. Nicholson G. Raghu M. Selman A. Wells Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project Am. J. Respir. Crit. Care Med. 177 2008 1338 1347 10.1164/rccm.200611-1685OC W.D. Travis, G. Hunninghake, T.E. King, Jr., D.A. Lynch, T.V. Colby, J.R. Galvin, K.K. Brown, M.P. Chung, J.F. Cordier, R.M. du Bois, K.R. Flaherty, T.J. Franks, D.M. Hansell, T.E. Hartman, E.A. Kazerooni, D.S. Kim, M. Kitaichi, T. Koyama, F.J. Martinez, S. Nagai, D.E. Midthun, N.L. Muller, A.G. Nicholson, G. Raghu, M. Selman, A. Wells, Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project, Am J Respir Crit Care Med 177 (2008) 1338–1347. https://doi.org/10.1164/rccm.200611–1685OC. [22] W.D. Travis U. Costabel D.M. Hansell T.E. King Jr. D.A. Lynch A.G. Nicholson C.J. Ryerson J.H. Ryu M. Selman A.U. Wells J. Behr D. Bouros K.K. Brown T.V. Colby H.R. Collard C.R. Cordeiro V. Cottin B. Crestani M. Drent R.F. Dudden J. Egan K. Flaherty C. Hogaboam Y. Inoue T. Johkoh D.S. Kim M. Kitaichi J. Loyd F.J. Martinez J. Myers S. Protzko G. Raghu L. Richeldi N. Sverzellati J. Swigris D. Valeyre A.E.Co.I.I. Pneumonias An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am. J. Respir. Crit. Care Med. 188 2013 733 748 10.1164/rccm.201308-1483ST W.D. Travis, U. Costabel, D.M. Hansell, T.E. King, Jr., D.A. Lynch, A.G. Nicholson, C.J. Ryerson, J.H. Ryu, M. Selman, A.U. Wells, J. Behr, D. Bouros, K.K. Brown, T.V. Colby, H.R. Collard, C.R. Cordeiro, V. Cottin, B. Crestani, M. Drent, R.F. Dudden, J. Egan, K. Flaherty, C. Hogaboam, Y. Inoue, T. Johkoh, D.S. Kim, M. Kitaichi, J. Loyd, F.J. Martinez, J. Myers, S. Protzko, G. Raghu, L. Richeldi, N. Sverzellati, J. Swigris, D. Valeyre, A.E.Co.I.I. Pneumonias, An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med 188 (2013) 733–748. https://doi.org/10.1164/rccm.201308–1483ST. [23] A.C. Henriet E. Diot S. Marchand-Adam A. de Muret O. Favelle B. Crestani P. Diot Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren’s syndrome Eur. Respir. Rev. 19 2010 161 163 10.1183/09059180.00002410 A.C. Henriet, E. Diot, S. Marchand-Adam, A. de Muret, O. Favelle, B. Crestani, P. Diot, Organising pneumonia can be the inaugural manifestation in connective tissue diseases, including Sjogren's syndrome, Eur Respir Rev 19 (2010) 161–163. https://doi.org/10.1183/09059180.00002410. [24] L. Pan Y. Liu R. Sun M. Fan G. Shi Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study Clin. Dev. Immunol. 2013 2013 121578 10.1155/2013/121578 L. Pan, Y. Liu, R. Sun, M. Fan, G. Shi, Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study, Clin Dev Immunol 2013 (2013) 121578. https://doi.org/10.1155/2013/121578. [25] J.H. Chung C.W. Cox S.M. Montner A. Adegunsoye J.M. Oldham A.N. Husain R. Vij I. Noth D.A. Lynch M.E. Strek CT features of the usual interstitial pneumonia pattern: differentiating connective tissue disease-associated interstitial lung disease from idiopathic pulmonary fibrosis AJR Am. J. Roentgenol. 210 2018 307 313 10.2214/AJR.17.18384 J.H. Chung, C.W. Cox, S.M. Montner, A. Adegunsoye, J.M. Oldham, A.N. Husain, R. Vij, I. Noth, D.A. Lynch, M.E. Strek, CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis, AJR Am J Roentgenol 210 (2018) 307–313. https://doi.org/10.2214/AJR.17.18384. [26] H. Yamakawa T. Ogura S. Sato T. Nishizawa R. Kawabe T. Oba A. Kato M. Horikoshi K. Akasaka M. Amano K. Kuwano H. Sasaki T. Baba H. Matsushima The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease Respir. Med 172 2020 106125 10.1016/j.rmed.2020.106125 H. Yamakawa, T. Ogura, S. Sato, T. Nishizawa, R. Kawabe, T. Oba, A. Kato, M. Horikoshi, K. Akasaka, M. Amano, K. Kuwano, H. Sasaki, T. Baba, H. Matsushima, The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease, Respir Med 172 (2020) 106125. https://doi.org/10.1016/j.rmed.2020.106125. [27] I.N. Park D.S. Kim T.S. Shim C.M. Lim S.D. Lee Y. Koh W.S. Kim W.D. Kim S.J. Jang T.V. Colby Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis Chest 132 2007 214 220 10.1378/chest.07-0323 I.N. Park, D.S. Kim, T.S. Shim, C.M. Lim, S.D. Lee, Y. Koh, W.S. Kim, W.D. Kim, S.J. Jang, T.V. Colby, Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis, Chest 132 (2007) 214–220. https://doi.org/10.1378/chest.07–0323. [28] F. Schneider J. Gruden H.D. Tazelaar K.O. Leslie Pleuropulmonary pathology in patients with rheumatic disease Arch. Pathol. Lab Med. 136 2012 1242 1252 10.5858/arpa.2012-0248-SA F. Schneider, J. Gruden, H.D. Tazelaar, K.O. Leslie, Pleuropulmonary pathology in patients with rheumatic disease, Arch Pathol Lab Med 136 (2012) 1242–1252. https://doi.org/10.5858/arpa.2012–0248-SA. [29] T.V. Colby Pulmonary pathology in patients with systemic autoimmune diseases Clin. Chest Med. 19 1998 587 612 10.1016/s0272-5231(05)70105-2 T.V. Colby, Pulmonary pathology in patients with systemic autoimmune diseases, Clin Chest Med 19 (1998) 587–612, vii. https://doi.org/10.1016/s0272–5231(05)70105–2. [30] M. Vivero R.F. Padera Histopathology of lung disease in the connective tissue diseases Rheum. Dis. Clin. North Am. 41 2015 197 211 10.1016/j.rdc.2014.12.002 M. Vivero, R.F. Padera, Histopathology of lung disease in the connective tissue diseases, Rheum Dis Clin North Am 41 (2015) 197–211. https://doi.org/10.1016/j.rdc.2014.12.002. [31] D. Tansey A.U. Wells T.V. Colby S. Ip A. Nikolakoupolou R.M. du Bois D.M. Hansell A.G. Nicholson Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis Histopathology 44 2004 585 596 10.1111/j.1365-2559.2004.01896.x D. Tansey, A.U. Wells, T.V. Colby, S. Ip, A. Nikolakoupolou, R.M. du Bois, D.M. Hansell, A.G. Nicholson, Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis, Histopathology 44 (2004) 585–596. https://doi.org/10.1111/j.1365–2559.2004.01896.x. [32] J.J. Solomon A. Fischer Connective tissue disease-associated interstitial lung disease: a focused review J. Intensive Care Med. 30 2015 392 400 10.1177/0885066613516579 J.J. Solomon, A. Fischer, Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review, J Intensive Care Med 30 (2015) 392–400. https://doi.org/10.1177/0885066613516579. [33] R.P. Oliveira R. Ribeiro L. Melo B. Grima S. Oliveira J.D. Alves Connective tissue disease-associated interstitial lung disease Pulmonology 2020 10.1016/j.pulmoe.2020.01.004 R.P. Oliveira, R. Ribeiro, L. Melo, B. Grima, S. Oliveira, J.D. Alves, Connective tissue disease-associated interstitial lung disease, Pulmonology (2020). https://doi.org/10.1016/j.pulmoe.2020.01.004. [34] M. Gutsche G.D. Rosen J.J. Swigris Connective tissue disease-associated interstitial lung disease: a review Curr. Respir. Care Rep. 1 2012 224 232 10.1007/s13665-012-0028-7 M. Gutsche, G.D. Rosen, J.J. Swigris, Connective Tissue Disease-associated Interstitial Lung Disease: A review, Curr Respir Care Rep 1 (2012) 224–232. https://doi.org/10.1007/s13665–012-0028–7. [35] Y. Homma Y. Ohtsuka K. Tanimura H. Kusaka M. Munakata Y. Kawakami H. Ogasawara Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration 62 1995 248 251 10.1159/000196457 Y. Homma, Y. Ohtsuka, K. Tanimura, H. Kusaka, M. Munakata, Y. Kawakami, H. Ogasawara, Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia?, Respiration 62 (1995) 248–251. https://doi.org/10.1159/000196457. [36] E.A. Kim T. Johkoh K.S. Lee K. Ichikado E.M. Koh T.S. Kim E.Y. Kim Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation J. Comput. Assist Tomogr. 25 2001 757 763 10.1097/00004728-200109000-00015 E.A. Kim, T. Johkoh, K.S. Lee, K. Ichikado, E.M. Koh, T.S. Kim, E.Y. Kim, Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation, J Comput Assist Tomogr 25 (2001) 757–763. https://doi.org/10.1097/00004728–200109000-00015. [37] A.U. Wells M.B. Rubens R.M. du Bois D.M. Hansell Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern AJR Am. J. Roentgenol. 161 1993 1159 1165 10.2214/ajr.161.6.8249719 A.U. Wells, M.B. Rubens, R.M. du Bois, D.M. Hansell, Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern, AJR Am J Roentgenol 161 (1993) 1159–1165. https://doi.org/10.2214/ajr.161.6.8249719. [38] T.E. Hartman S.L. Primack E.Y. Kang S.J. Swensen D.M. Hansell G. McGuinness N.L. Muller Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia Assess. Ser. CT Chest 110 1996 378 382 10.1378/chest.110.2.378 T.E. Hartman, S.L. Primack, E.Y. Kang, S.J. Swensen, D.M. Hansell, G. McGuinness, N.L. Muller, Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT, Chest 110 (1996) 378–382. https://doi.org/10.1378/chest.110.2.378. [39] T.J. Doyle P.F. Dellaripa K. Batra M.L. Frits C.K. Iannaccone H. Hatabu M. Nishino M.E. Weinblatt D.P. Ascherman G.R. Washko G.M. Hunninghake A.M.K. Choi N.A. Shadick I.O. Rosas Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis Chest 146 2014 41 50 10.1378/chest.13-1394 T.J. Doyle, P.F. Dellaripa, K. Batra, M.L. Frits, C.K. Iannaccone, H. Hatabu, M. Nishino, M.E. Weinblatt, D.P. Ascherman, G.R. Washko, G.M. Hunninghake, A.M.K. Choi, N.A. Shadick, I.O. Rosas, Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis, Chest 146 (2014) 41–50. https://doi.org/10.1378/chest.13–1394. [40] B.R. Gochuico N.A. Avila C.K. Chow L.J. Novero H.P. Wu P. Ren S.D. MacDonald W.D. Travis M.P. Stylianou I.O. Rosas Progressive preclinical interstitial lung disease in rheumatoid arthritis Arch. Intern Med. 168 2008 159 166 10.1001/archinternmed.2007.59 B.R. Gochuico, N.A. Avila, C.K. Chow, L.J. Novero, H.P. Wu, P. Ren, S.D. MacDonald, W.D. Travis, M.P. Stylianou, I.O. Rosas, Progressive preclinical interstitial lung disease in rheumatoid arthritis, Arch Intern Med 168 (2008) 159–166. https://doi.org/10.1001/archinternmed.2007.59. [41] L. Kawano-Dourado T.J. Doyle K. Bonfiglioli M.V.Y. Sawamura R.H. Nakagawa F.E. Arimura H.J. Lee D.A.S. Rangel C. Bueno C.R.R. Carvalho M.L. Sabbag C. Molina I.O. Rosas R.A. Kairalla Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis Chest 158 2020 1546 1554 10.1016/j.chest.2020.04.061 L. Kawano-Dourado, T.J. Doyle, K. Bonfiglioli, M.V.Y. Sawamura, R.H. Nakagawa, F.E. Arimura, H.J. Lee, D.A.S. Rangel, C. Bueno, C.R.R. Carvalho, M.L. Sabbag, C. Molina, I.O. Rosas, R.A. Kairalla, Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis, Chest 158 (2020) 1546–1554. https://doi.org/10.1016/j.chest.2020.04.061. [42] B. Lucchino M. Di Paolo C. Gioia M. Vomero D. Diacinti C. Mollica C. Alessandri D. Diacinti P. Palange M. Di Franco Identification of subclinical lung involvement in ACPA-positive subjects through functional assessment and serum biomarkers Int J. Mol. Sci. 21 2020 10.3390/ijms21145162 B. Lucchino, M. Di Paolo, C. Gioia, M. Vomero, D. Diacinti, C. Mollica, C. Alessandri, D. Diacinti, P. Palange, M. Di Franco, Identification of Subclinical Lung Involvement in ACPA-Positive Subjects through Functional Assessment and Serum Biomarkers, Int J Mol Sci 21 (2020). https://doi.org/10.3390/ijms21145162. [43] T.J. Doyle G.M. Hunninghake I.O. Rosas Subclinical interstitial lung disease: why you should care Am. J. Respir. Crit. Care Med. 185 2012 1147 1153 10.1164/rccm.201108-1420PP T.J. Doyle, G.M. Hunninghake, I.O. Rosas, Subclinical interstitial lung disease: why you should care, Am J Respir Crit Care Med 185 (2012) 1147–1153. https://doi.org/10.1164/rccm.201108–1420PP. [44] V. Cottin Significance of connective tissue diseases features in pulmonary fibrosis Eur. Respir. Rev. 22 2013 273 280 10.1183/09059180.00003013 V. Cottin, Significance of connective tissue diseases features in pulmonary fibrosis, Eur Respir Rev 22 (2013) 273–280. https://doi.org/10.1183/09059180.00003013. [45] A. Fischer K.M. Antoniou K.K. Brown J. Cadranel T.J. Corte R.M. du Bois J.S. Lee K.O. Leslie D.A. Lynch E.L. Matteson M. Mosca I. Noth L. Richeldi M.E. Strek J.J. Swigris A.U. Wells S.G. West H.R. Collard V. Cottin E.A.T.Fo.U.Fo CTD-ILD An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Eur. Respir. J. 46 2015 976 987 10.1183/13993003.00150-2015 A. Fischer, K.M. Antoniou, K.K. Brown, J. Cadranel, T.J. Corte, R.M. du Bois, J.S. Lee, K.O. Leslie, D.A. Lynch, E.L. Matteson, M. Mosca, I. Noth, L. Richeldi, M.E. Strek, J.J. Swigris, A.U. Wells, S.G. West, H.R. Collard, V. Cottin, E.A.T.Fo.U.Fo CTD-ILD, An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features, Eur Respir J 46 (2015) 976–987. https://doi.org/10.1183/13993003.00150–2015. [46] A. Fischer J.J. Swigris S.D. Groshong C.D. Cool H. Sahin D.A. Lynch D. Curran-Everett J.Z. Gillis R.T. Meehan K.K. Brown Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival Chest 134 2008 601 605 10.1378/chest.08-0053 A. Fischer, J.J. Swigris, S.D. Groshong, C.D. Cool, H. Sahin, D.A. Lynch, D. Curran-Everett, J.Z. Gillis, R.T. Meehan, K.K. Brown, Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival, Chest 134 (2008) 601–605. https://doi.org/10.1378/chest.08–0053. [47] Y. Nakamura T. Suda Y. Kaida M. Kono H. Hozumi D. Hashimoto N. Enomoto T. Fujisawa N. Inui S. Imokawa K. Yasuda T. Shirai H. Suganuma S. Morita H. Hayakawa Y. Takehara T.V. Colby K. Chida Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases Respir. Med 106 2012 1164 1169 10.1016/j.rmed.2012.04.004 Y. Nakamura, T. Suda, Y. Kaida, M. Kono, H. Hozumi, D. Hashimoto, N. Enomoto, T. Fujisawa, N. Inui, S. Imokawa, K. Yasuda, T. Shirai, H. Suganuma, S. Morita, H. Hayakawa, Y. Takehara, T.V. Colby, K. Chida, Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases, Respir Med 106 (2012) 1164–1169. https://doi.org/10.1016/j.rmed.2012.04.004. [48] D. Bouros A.U. Wells A.G. Nicholson T.V. Colby V. Polychronopoulos P. Pantelidis P.L. Haslam D.A. Vassilakis C.M. Black R.M. du Bois Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome Am. J. Respir. Crit. Care Med. 165 2002 1581 1586 10.1164/rccm.2106012 D. Bouros, A.U. Wells, A.G. Nicholson, T.V. Colby, V. Polychronopoulos, P. Pantelidis, P.L. Haslam, D.A. Vassilakis, C.M. Black, R.M. du Bois, Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome, Am J Respir Crit Care Med 165 (2002) 1581–1586. https://doi.org/10.1164/rccm.2106012. [49] T.A. Winstone D. Assayag P.G. Wilcox J.V. Dunne C.J. Hague J. Leipsic H.R. Collard C.J. Ryerson Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review Chest 146 2014 422 436 10.1378/chest.13-2626 T.A. Winstone, D. Assayag, P.G. Wilcox, J.V. Dunne, C.J. Hague, J. Leipsic, H.R. Collard, C.J. Ryerson, Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review, Chest 146 (2014) 422–436. https://doi.org/10.1378/chest.13–2626. [50] Y. Tsuchiya N. Takayanagi H. Sugiura Y. Miyahara D. Tokunaga Y. Kawabata Y. Sugita Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome Eur. Respir. J. 37 2011 1411 1417 10.1183/09031936.00019210 Y. Tsuchiya, N. Takayanagi, H. Sugiura, Y. Miyahara, D. Tokunaga, Y. Kawabata, Y. Sugita, Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome, Eur Respir J 37 (2011) 1411–1417. https://doi.org/10.1183/09031936.00019210. [51] J. Chen Y. Shi X. Wang H. Huang D. Ascherman Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease Clin. Dev. Immunol. 2013 2013 406927 10.1155/2013/406927 J. Chen, Y. Shi, X. Wang, H. Huang, D. Ascherman, Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease, Clin Dev Immunol 2013 (2013) 406927. https://doi.org/10.1155/2013/406927. [52] L. Vanaken N. Landini J. Lenaerts E. Claeys J. Lenaerts W.A. Wuyts J. Verschakelen E. De Langhe Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment Clin. Rheuma 39 2020 3393 3400 10.1007/s10067-020-05105-4 L. Vanaken, N. Landini, J. Lenaerts, E. Claeys, J. Lenaerts, W.A. Wuyts, J. Verschakelen, E. De Langhe, Progressive lung fibrosis and mortality can occur in early systemic sclerosis patients without pulmonary abnormalities at baseline assessment, Clin Rheumatol 39 (2020) 3393–3400. https://doi.org/10.1007/s10067–020-05105–4. [53] M. Uffmann H.P. Kiener A.A. Bankier M.M. Baldt T. Zontsich C.J. Herold Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests J. Thorac. Imaging 16 2001 282 289 10.1097/00005382-200110000-00009 M. Uffmann, H.P. Kiener, A.A. Bankier, M.M. Baldt, T. Zontsich, C.J. Herold, Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests, J Thorac Imaging 16 (2001) 282–289. https://doi.org/10.1097/00005382–200110000-00009. [54] T.J. Richards A. Eggebeen K. Gibson S. Yousem C. Fuhrman B.R. Gochuico N. Fertig C.V. Oddis N. Kaminski I.O. Rosas D.P. Ascherman Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease Arthritis Rheum. 60 2009 2183 2192 10.1002/art.24631 T.J. Richards, A. Eggebeen, K. Gibson, S. Yousem, C. Fuhrman, B.R. Gochuico, N. Fertig, C.V. Oddis, N. Kaminski, I.O. Rosas, D.P. Ascherman, Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease, Arthritis Rheum 60 (2009) 2183–2192. https://doi.org/10.1002/art.24631. [55] D.A. Pereira O.M. Dias G.E. Almeida M.S. Araujo L.B. Kawano-Dourado B.G. Baldi R.A. Kairalla C.R. Carvalho Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features J. Bras. Pneumol. 41 2015 151 160 10.1590/S1806-37132015000004443 D.A. Pereira, O.M. Dias, G.E. Almeida, M.S. Araujo, L.B. Kawano-Dourado, B.G. Baldi, R.A. Kairalla, C.R. Carvalho, Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features, J Bras Pneumol 41 (2015) 151–160. https://doi.org/10.1590/S1806–37132015000004443. [56] M.R. Arbuckle M.T. McClain M.V. Rubertone R.H. Scofield G.J. Dennis J.A. James J.B. Harley Development of autoantibodies before the clinical onset of systemic lupus erythematosus New Engl. J. Med. 349 2003 1526 1533 10.1056/NEJMoa021933 M.R. Arbuckle, M.T. McClain, M.V. Rubertone, R.H. Scofield, G.J. Dennis, J.A. James, J.B. Harley, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N Engl J Med 349 (2003) 1526–1533. https://doi.org/10.1056/NEJMoa021933. [57] M.M. Nielen D. van Schaardenburg H.W. Reesink R.J. van de Stadt I.E. van der Horst-Bruinsma M.H. de Koning M.R. Habibuw J.P. Vandenbroucke B.A. Dijkmans Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors Arthritis Rheum. 50 2004 380 386 10.1002/art.20018 M.M. Nielen, D. van Schaardenburg, H.W. Reesink, R.J. van de Stadt, I.E. van der Horst-Bruinsma, M.H. de Koning, M.R. Habibuw, J.P. Vandenbroucke, B.A. Dijkmans, Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors, Arthritis Rheum 50 (2004) 380–386. https://doi.org/10.1002/art.20018.